RRR

ROPHARMA BRASOV

No trades
See on Supercharts
Market capitalization
‪91.01 M‬RON
‪7.72 M‬RON
‪1.12 B‬RON
‪189.73 M‬
Beta (1Y)
−0.11
Employees (FY)
‪1.7 K‬
Change (1Y)
+53 +3.23%
Revenue / Employee (1Y)
‪145.90 K‬RON
Net income / Employee (1Y)
‪1.01 K‬RON

About ROPHARMA BRASOV


CEO
Mihai Miron
Headquarters
Brasov
Founded
1952
ISIN
ROIAFRACNOR4
FIGI
BBG000CMZPT2
Ropharma SA engages in the production, distribution, and trade of pharmaceuticals. It also offers medical services. The company was founded in 1952 and is headquartered in Brasov, Romania.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of RPH is 0.178 RON — it has increased by 1.14% in the past 24 hours. Watch ROPHARMA BRASOV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BVB exchange ROPHARMA BRASOV stocks are traded under the ticker RPH.
RPH stock has risen by 1.14% compared to the previous week, the month change is a −1.11% fall, over the last year ROPHARMA BRASOV has showed a −1.66% decrease.
RPH reached its all-time high on Jan 24, 2011 with the price of 1.000 RON, and its all-time low was 0.160 RON and was reached on Mar 7, 2022. View more price dynamics on RPH chart.
See other stocks reaching their highest and lowest prices.
RPH stock is 1.70% volatile and has beta coefficient of −0.11. Track ROPHARMA BRASOV stock price on the chart and check out the list of the most volatile stocks — is ROPHARMA BRASOV there?
Today ROPHARMA BRASOV has the market capitalization of ‪91.01 M‬, it has increased by 1.73% over the last week.
Yes, you can track ROPHARMA BRASOV financials in yearly and quarterly reports right on TradingView.
RPH net income for the last half-year is ‪−3.21 M‬ RON, while the previous report showed ‪3.25 M‬ RON of net income which accounts for −198.92% change. Track more ROPHARMA BRASOV financial stats to get the full picture.
No, RPH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 4, 2024, the company has ‪1.70 K‬ employees. See our rating of the largest employees — is ROPHARMA BRASOV on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ROPHARMA BRASOV EBITDA is ‪45.01 M‬ RON, and current EBITDA margin is 4.07%. See more stats in ROPHARMA BRASOV financial statements.
Like other stocks, RPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ROPHARMA BRASOV stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ROPHARMA BRASOV technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ROPHARMA BRASOV stock shows the sell signal. See more of ROPHARMA BRASOV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.